Literature DB >> 23868156

Automated white matter total lesion volume segmentation in diabetes.

J A Maldjian1, C T Whitlow, B N Saha, G Kota, C Vandergriff, E M Davenport, J Divers, B I Freedman, D W Bowden.   

Abstract

BACKGROUND AND
PURPOSE: WM lesion segmentation is often performed with the use of subjective rating scales because manual methods are laborious and tedious; however, automated methods are now available. We compared the performance of total lesion volume grading computed by use of an automated WM lesion segmentation algorithm with that of subjective rating scales and expert manual segmentation in a cohort of subjects with type 2 diabetes.
MATERIALS AND METHODS: Structural T1 and FLAIR MR imaging data from 50 subjects with diabetes (age, 67.7 ± 7.2 years) and 50 nondiabetic sibling pairs (age, 67.5 ± 9.4 years) were evaluated in an institutional review board-approved study. WM lesion segmentation maps and total lesion volume were generated for each subject by means of the Statistical Parametric Mapping (SPM8) Lesion Segmentation Toolbox. Subjective WM lesion grade was determined by means of a 0-9 rating scale by 2 readers. Ground-truth total lesion volume was determined by means of manual segmentation by experienced readers. Correlation analyses compared manual segmentation total lesion volume with automated and subjective evaluation methods.
RESULTS: Correlation between average lesion segmentation and ground-truth total lesion volume was 0.84. Maximum correlation between the Lesion Segmentation Toolbox and ground-truth total lesion volume (ρ = 0.87) occurred at the segmentation threshold of k = 0.25, whereas maximum correlation between subjective lesion segmentation and the Lesion Segmentation Toolbox (ρ = 0.73) occurred at k = 0.15. The difference between the 2 correlation estimates with ground-truth was not statistically significant. The lower segmentation threshold (0.15 versus 0.25) suggests that subjective raters overestimate WM lesion burden.
CONCLUSIONS: We validate the Lesion Segmentation Toolbox for determining total lesion volume in diabetes-enriched populations and compare it with a common subjective WM lesion rating scale. The Lesion Segmentation Toolbox is a readily available substitute for subjective WM lesion scoring in studies of diabetes and other populations with changes of leukoaraiosis.

Entities:  

Mesh:

Year:  2013        PMID: 23868156      PMCID: PMC4038900          DOI: 10.3174/ajnr.A3590

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  26 in total

Review 1.  Association between pathological and MRI findings in multiple sclerosis.

Authors:  Massimo Filippi; Maria A Rocca; Frederik Barkhof; Wolfgang Brück; Jacqueline T Chen; Giancarlo Comi; Gabriele DeLuca; Nicola De Stefano; Bradley J Erickson; Nikos Evangelou; Franz Fazekas; Jeroen J G Geurts; Claudia Lucchinetti; David H Miller; Daniel Pelletier; Bogdan F Gh Popescu; Hans Lassmann
Journal:  Lancet Neurol       Date:  2012-03-19       Impact factor: 44.182

2.  Microstructural white matter abnormalities in type 2 diabetes mellitus: a diffusion tensor imaging study.

Authors:  Jung-Lung Hsu; Yen-Ling Chen; Jyu-Gang Leu; Fu-Shan Jaw; Cheng-Hui Lee; Yuh-Feng Tsai; Chien-Yeh Hsu; Chyi-Huey Bai; Alexander Leemans
Journal:  Neuroimage       Date:  2011-09-24       Impact factor: 6.556

3.  Automated and visual scoring methods of cerebral white matter hyperintensities: relation with age and cognitive function.

Authors:  A M Tiehuis; K L Vincken; W P T M Mali; L J Kappelle; P Anbeek; A Algra; G J Biessels
Journal:  Cerebrovasc Dis       Date:  2007-11-22       Impact factor: 2.762

Review 4.  Endothelial dysfunction in lacunar stroke: a systematic review.

Authors:  Iris L H Knottnerus; Hugo Ten Cate; Jan Lodder; Fons Kessels; Robert J van Oostenbrugge
Journal:  Cerebrovasc Dis       Date:  2009-04-16       Impact factor: 2.762

5.  An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis.

Authors:  Paul Schmidt; Christian Gaser; Milan Arsic; Dorothea Buck; Annette Förschler; Achim Berthele; Muna Hoshi; Rüdiger Ilg; Volker J Schmid; Claus Zimmer; Bernhard Hemmer; Mark Mühlau
Journal:  Neuroimage       Date:  2011-11-18       Impact factor: 6.556

Review 6.  Age-related cerebral white matter disease (leukoaraiosis): a review.

Authors:  Basil E Grueter; Ursula G Schulz
Journal:  Postgrad Med J       Date:  2011-12-18       Impact factor: 2.401

Review 7.  Review of the Diabetes Heart Study (DHS) family of studies: a comprehensively examined sample for genetic and epidemiological studies of type 2 diabetes and its complications.

Authors:  Donald W Bowden; Amanda J Cox; Barry I Freedman; Christina E Hugenschimdt; Lynne E Wagenknecht; David Herrington; Subhashish Agarwal; Thomas C Register; Joseph A Maldjian; Maggie C-Y Ng; Fang-Chi Hsu; Carl D Langefeld; Jeff D Williamson; J Jeffrey Carr
Journal:  Rev Diabet Stud       Date:  2010-11-10

8.  Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes.

Authors:  Jeroen de Bresser; Audrey M Tiehuis; Esther van den Berg; Yael D Reijmer; Cynthia Jongen; L Jaap Kappelle; Willem P Mali; Max A Viergever; Geert Jan Biessels
Journal:  Diabetes Care       Date:  2010-03-18       Impact factor: 19.112

9.  Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study.

Authors:  Stéphanie Debette; Alexa Beiser; Charles DeCarli; Rhoda Au; Jayandra J Himali; Margaret Kelly-Hayes; Jose R Romero; Carlos S Kase; Philip A Wolf; Sudha Seshadri
Journal:  Stroke       Date:  2010-02-18       Impact factor: 7.914

Review 10.  The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis.

Authors:  Stéphanie Debette; H S Markus
Journal:  BMJ       Date:  2010-07-26
View more
  29 in total

1.  Associations between anxiety and depression symptoms and cognitive testing and neuroimaging in type 2 diabetes.

Authors:  Laura M Raffield; Gretchen A Brenes; Amanda J Cox; Barry I Freedman; Christina E Hugenschmidt; Fang-Chi Hsu; Jianzhao Xu; Benjamin C Wagner; Jeff D Williamson; Joseph A Maldjian; Donald W Bowden
Journal:  J Diabetes Complications       Date:  2015-09-25       Impact factor: 2.852

2.  Structural and functional assessment of the brain in European Americans with mild-to-moderate kidney disease: Diabetes Heart Study-MIND.

Authors:  Mariana Murea; Fang-Chi Hsu; Amanda J Cox; Christina E Hugenschmidt; Jianzhao Xu; Jeremy N Adams; Laura M Raffield; Christopher T Whitlow; Joseph A Maldjian; Donald W Bowden; Barry I Freedman
Journal:  Nephrol Dial Transplant       Date:  2015-02-26       Impact factor: 5.992

3.  Cerebral Structure and Cognitive Performance in African Americans and European Americans With Type 2 Diabetes.

Authors:  Fang-Chi Hsu; Kaycee M Sink; Christina E Hugenschmidt; Jeff D Williamson; Timothy M Hughes; Nicholette D Palmer; Jianzhao Xu; S Carrie Smith; Benjamin C Wagner; Christopher T Whitlow; Donald W Bowden; Joseph A Maldjian; Jasmin Divers; Barry I Freedman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-03-02       Impact factor: 6.053

4.  Relationships between Cognitive Performance, Neuroimaging and Vascular Disease: The DHS-MIND Study.

Authors:  Fang-Chi Hsu; Laura M Raffield; Christina E Hugenschmidt; Amanda Cox; Jianzhao Xu; J Jeffery Carr; Barry I Freedman; Joseph A Maldjian; Jeff D Williamson; Donald W Bowden
Journal:  Neuroepidemiology       Date:  2015-07-14       Impact factor: 3.282

Review 5.  White matter hyperintensities, cognitive impairment and dementia: an update.

Authors:  Niels D Prins; Philip Scheltens
Journal:  Nat Rev Neurol       Date:  2015-02-17       Impact factor: 42.937

6.  APOE Genotypes Associate With Cognitive Performance but Not Cerebral Structure: Diabetes Heart Study MIND.

Authors:  Nicholette D Palmer Allred; Laura M Raffield; Joycelyn C Hardy; Fang-Chi Hsu; Jasmin Divers; Jianzhao Xu; S Carrie Smith; Christina E Hugenschmidt; Benjamin C Wagner; Christopher T Whitlow; Kaycee M Sink; Joseph A Maldjian; Jeff D Williamson; Donald W Bowden; Barry I Freedman
Journal:  Diabetes Care       Date:  2016-10-04       Impact factor: 19.112

7.  Heritability and genetic association analysis of neuroimaging measures in the Diabetes Heart Study.

Authors:  Laura M Raffield; Amanda J Cox; Christina E Hugenschmidt; Barry I Freedman; Carl D Langefeld; Jeff D Williamson; Fang-Chi Hsu; Joseph A Maldjian; Donald W Bowden
Journal:  Neurobiol Aging       Date:  2014-11-20       Impact factor: 4.673

8.  APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume.

Authors:  Barry I Freedman; Crystal A Gadegbeku; R Nick Bryan; Nicholas M Pajewski; Jasmin Divers; Nicholette D Palmer; Pamela J Hicks; Lijun Ma; Michael V Rocco; S Carrie Smith; Jianzhao Xu; Christopher T Whitlow; Benjamin C Wagner; Carl D Langefeld; Amret T Hawfield; Jeffrey T Bates; Alan J Lerner; Dominic S Raj; Mohammad S Sadaghiani; Robert D Toto; Jackson T Wright; Donald W Bowden; Jeff D Williamson; Kaycee M Sink; Joseph A Maldjian
Journal:  Kidney Int       Date:  2016-06-22       Impact factor: 10.612

9.  Analysis of advanced glycation end products in the DHS Mind Study.

Authors:  Jeremy N Adams; Susan E Martelle; Laura M Raffield; Barry I Freedman; Carl D Langefeld; Fang-Chi Hsu; Joseph A Maldjian; Jeff D Williamson; Christina E Hugenschmidt; J Jeffery Carr; Amanda J Cox; Donald W Bowden
Journal:  J Diabetes Complications       Date:  2015-11-30       Impact factor: 2.852

10.  Regional Gray Matter Atrophy Coexistent with Occipital Periventricular White Matter Hyper Intensities.

Authors:  Dazhi Duan; Congyang Li; Lin Shen; Chun Cui; Tongsheng Shu; Jian Zheng
Journal:  Front Aging Neurosci       Date:  2016-09-07       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.